Related references
Note: Only part of the references are listed.Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder
Joshua Liberman et al.
MEDICINE (2023)
Long-term safety of ketamine and esketamine in treatment of depression
Sina Nikayin et al.
EXPERT OPINION ON DRUG SAFETY (2022)
A retrospective analysis of ketamine intravenous therapy for depression in real-world care settings
L. Alison McInnes et al.
JOURNAL OF AFFECTIVE DISORDERS (2022)
Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis
Yazen Alnefeesi et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2022)
Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials
Jacob S. Aday et al.
PSYCHOPHARMACOLOGY (2022)
Real-world depression, anxiety and safety outcomes of intramuscular ketamine treatment: a retrospective descriptive cohort study
Sachin Ahuja et al.
BMC PSYCHIATRY (2022)
At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial
Thomas D. Hull et al.
JOURNAL OF AFFECTIVE DISORDERS (2022)
Safety, effectiveness and tolerability of sublingual ketamine in depression and anxiety: A retrospective study of off-label, at-home use
Kazi Hassan et al.
FRONTIERS IN PSYCHIATRY (2022)
Clinical Effectiveness 01 intravenous Racemic etamineTnr Bions in a Large Community Sample of Patients With Treatment- Resistant Depression, Suicidal Ideation, and Generalized
Patrick A. Oliver et al.
JOURNAL OF CLINICAL PSYCHIATRY (2022)
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
Roger S. McIntyre et al.
AMERICAN JOURNAL OF PSYCHIATRY (2021)
The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorder
Roger S. McIntyre et al.
BIPOLAR DISORDERS (2020)
The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence
Roger S. McIntyre et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials
Joanna Kryst et al.
PHARMACOLOGICAL REPORTS (2020)
Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence
Nelson B. Rodrigues et al.
EXPERT OPINION ON DRUG SAFETY (2020)
Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder
Wei Zheng et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression
Naji C. Salloum et al.
DEPRESSION AND ANXIETY (2019)
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial
Jennifer L. Phillips et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
Samuel T. Wilkinson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Trajectories of Acute Antidepressant Efficacy: How Long to Wait for Response? A Systematic Review and Meta-Analysis of Long-Term, Placebo-Controlled Acute Treatment Trials
Jonathan Henssler et al.
JOURNAL OF CLINICAL PSYCHIATRY (2018)
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
Jaskaran B. Singh et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
A single infusion of ketamine improves depression scores in patients with anxious bipolar depression
Dawn F. Ionescu et al.
BIPOLAR DISORDERS (2015)
Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety
Elizabeth D. Ballard et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2014)
Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
James W. Murrough et al.
BIOLOGICAL PSYCHIATRY (2013)
International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol
Leanne M. Williams et al.
TRIALS (2011)
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report
Maurizio Fava et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)